运动员心脏高级影像:区分生理适应与病理改变
本文为叙述性综述,旨在界定运动员心脏重构与病理结构改变之间的界限,重点阐述冠状动脉CT血管成像(CCTA)和心脏磁共振(CMR)在参赛前筛查中识别猝死风险运动员的作用。病理改变早期常较细微,与运动性心脏重构存在重叠,高级影像可无创评估冠状动脉并深度刻画心肌形态功能与结构特征。
要点
- 运动员心脏重构可与早期结构性病变重叠,阅片需警惕细微病理征象。
- CCTA可无创评估冠状动脉,CMR可深度刻画心肌形态功能与结构。
- 参赛前筛查中高级影像用于排除与运动性重构重叠的致命性病变。
核心结论
- CCTA与CMR可无创显示冠状动脉并提供心肌形态功能与结构特征,用于排除与运动员心脏重构重叠的致命性病理改变。
研究设计与样本
- 叙述性综述,未报告检索范围、纳入文献数量、样本量、中心数、设备或序列参数及参考标准。
临床应用与阅片要点
- 在参赛前筛查中,对疑似病理重构的运动员可借助CCTA评估冠状动脉、借助CMR刻画心肌结构,以排除致命性病变。
- 阅片需注意病理改变早期常较细微,且可与运动性心脏重构重叠,应仔细甄别。
局限性
- 本文为叙述性综述,未报告系统检索策略、纳入文献数量及证据分级,结论基于叙述性汇总。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Over the last decades, interest toward athlete's heart has progressively increased, leading to improve the knowledge on exercise-induced heart modifications. Sport may act as a trigger for life-threatening arrhythmias in patients with structural or electrical abnormalities, hence requiring to improve the diagnostic capability to differentiate physiological from pathological remodeling. Pathological alterations are often subtle at the initial stages; therefore, the challenge is to promptly identify athletes at risk of sudden cardiac death during the pre-participation screening protocols. Advanced imaging modalities such as coronary computed tomography angiography (CCTA) and cardiac magnetic resonance (CMR) can non-invasively depict coronary vessels and provide a deep morpho-functional and structural characterization of the myocardium, in order to rule out pathological life threatening alterations, which may overlap with athletes' heart remodeling. The purpose of the present narrative review is to provide an overview of most frequent diagnostic challenges, defining the boundaries between athlete's heart remodeling and pathological structural alteration with a focus on the role and importance of CCTA and CMR.
引用
- Palmisano A, Darvizeh F, Cundari G, et al. Advanced cardiac imaging in athlete's heart: unravelling the grey zone between physiologic adaptation and pathology. Radiol Med. 2021. PMID: 34420142. doi:10.1007/s11547-021-01411-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。